These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 11290333)

  • 1. The crystal structures of K(bm1) and K(bm8) reveal that subtle changes in the peptide environment impact thermostability and alloreactivity.
    Rudolph MG; Speir JA; Brunmark A; Mattsson N; Jackson MR; Peterson PA; Teyton L; Wilson IA
    Immunity; 2001 Mar; 14(3):231-42. PubMed ID: 11290333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conformational differences in major histocompatibility complex-peptide complexes can result in alloreactivity.
    Chattopadhyay S; Theobald M; Biggs J; Sherman LA
    J Exp Med; 1994 Jan; 179(1):213-9. PubMed ID: 8270866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T cell recognition of an engineered MHC class I molecule: implications for peptide-independent alloreactivity.
    Janković V; Remus K; Molano A; Nikolich-Zugich J
    J Immunol; 2002 Aug; 169(4):1887-92. PubMed ID: 12165513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell receptor (TCR) recognition of MHC class I variants: intermolecular second-site reversion provides evidence for peptide/MHC conformational variation.
    Dyall R; Fremont DH; Jameson SC; Nikolić-Zugić J
    J Exp Med; 1996 Jul; 184(1):253-8. PubMed ID: 8691139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point mutations in the beta chain CDR3 can alter the T cell receptor recognition pattern on an MHC class I/peptide complex over a broad interface area.
    Goyarts EC; Vegh Z; Kalergis AM; Hörig H; Papadopoulos NJ; Young AC; Thomson CT; Chang HC; Joyce S; Nathenson SG
    Mol Immunol; 1998 Jul; 35(10):593-607. PubMed ID: 9823758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structures of murine MHC Class I H-2 D(b) and K(b) molecules in complex with CTL epitopes from influenza A virus: implications for TCR repertoire selection and immunodominance.
    Meijers R; Lai CC; Yang Y; Liu JH; Zhong W; Wang JH; Reinherz EL
    J Mol Biol; 2005 Feb; 345(5):1099-110. PubMed ID: 15644207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Threshold tolerance in H-2Kb-specific TCR transgenic mice expressing mutant H-2Kb: conversion of helper-independent to helper-dependent CTL.
    Auphan N; Jézo-Brémond A; Schönrich G; Hämmerling G; Arnold B; Malissen B; Schmitt-Verhulst AM
    Int Immunol; 1992 Dec; 4(12):1419-28. PubMed ID: 1286065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The H-2Kk MHC peptide-binding groove anchors the backbone of an octameric antigenic peptide in an unprecedented mode.
    Kellenberger C; Roussel A; Malissen B
    J Immunol; 2005 Sep; 175(6):3819-25. PubMed ID: 16148128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of structural principles underlying three different modes of lymphocytic choriomeningitis virus escape from CTL recognition.
    Velloso LM; Michaëlsson J; Ljunggren HG; Schneider G; Achour A
    J Immunol; 2004 May; 172(9):5504-11. PubMed ID: 15100292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
    Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
    Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db mutant) mice. I. Full recognition of Kbm11 by Kb-restricted CTL.
    Stukart MJ; Boes J; Melief CJ
    J Immunol; 1984 Jul; 133(1):24-7. PubMed ID: 6202782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural definition of the H-2Kd peptide-binding motif.
    Mitaksov V; Fremont DH
    J Biol Chem; 2006 Apr; 281(15):10618-25. PubMed ID: 16473882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide-independent recognition by alloreactive cytotoxic T lymphocytes (CTL).
    Smith PA; Brunmark A; Jackson MR; Potter TA
    J Exp Med; 1997 Mar; 185(6):1023-33. PubMed ID: 9091576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for the restoration of TCR recognition of an MHC allelic variant by peptide secondary anchor substitution.
    Miley MJ; Messaoudi I; Metzner BM; Wu Y; Nikolich-Zugich J; Fremont DH
    J Exp Med; 2004 Dec; 200(11):1445-54. PubMed ID: 15557346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition of H-2Kb mutant target cells by Moloney virus-specific cytotoxic T lymphocytes from bm13 (H-2Db-mutant) mice. II. Relationship of Kbm3 and Kbm11 in restriction specificities and allodeterminants.
    Stukart MJ; Boes J; Melief CJ
    J Immunol; 1984 Jul; 133(1):28-32. PubMed ID: 6202783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses.
    Abrams SI; Stanziale SF; Lunin SD; Zaremba S; Schlom J
    Eur J Immunol; 1996 Feb; 26(2):435-43. PubMed ID: 8617315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide presentation by the MHC class Ib molecule, H2-M3.
    Smith GP; Dabhi VM; Pamer EG; Lindahl KF
    Int Immunol; 1994 Dec; 6(12):1917-26. PubMed ID: 7696209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zooming in on the hydrophobic ridge of H-2D(b): implications for the conformational variability of bound peptides.
    Ciatto C; Tissot AC; Tschopp M; Capitani G; Pecorari F; Plückthun A; Grütter MG
    J Mol Biol; 2001 Oct; 312(5):1059-71. PubMed ID: 11580250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural analysis of H2-Db class I molecules containing two different allelic forms of the type 1 diabetes susceptibility factor beta-2 microglobulin: implications for the mechanism underlying variations in antigen presentation.
    Roden MM; Brims DR; Fedorov AA; DiLorenzo TP; Almo SC; Nathenson SG
    Mol Immunol; 2006 Mar; 43(9):1370-8. PubMed ID: 16229893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of self peptides in the allogeneic cross-reactivity of CTLs.
    Kuzushima K; Sun R; van Bleek GM; Vegh Z; Nathenson SG
    J Immunol; 1995 Jul; 155(2):594-601. PubMed ID: 7541821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.